Register Financial Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$1 648
2023
Q3
$1 Hold
100
﹤0.01% 595
2023
Q2
$67 Hold
100
﹤0.01% 546
2023
Q1
$139 Hold
100
﹤0.01% 542
2022
Q4
$126 Buy
+100
New +$228 ﹤0.01% 780

Register Financial Advisors's NMTR Position: Q4 2023 in Review

Register Financial Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 100 shares — an estimated $1 sold.

Register Financial Advisors first reported a position in NMTR in Q4 2022 and held it in 4 quarters. The position peaked at $139 in Q1 2023. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.

  • Register Financial Advisors reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
  • Register Financial Advisors sold 100 9 Meters Biopharma shares in Q4 2023, an estimated $1.
  • Register Financial Advisors first reported a position in 9 Meters Biopharma in Q4 2022 and held it in 4 quarters.
  • Register Financial Advisors's 9 Meters Biopharma position peaked at $139 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.

Based on Register Financial Advisors's 13F filing for Q4 2023, filed 12 Jan 2024.